IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.255
EU - Europa 3.674
AS - Asia 699
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 9
AF - Africa 8
OC - Oceania 2
Totale 9.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.046
GB - Regno Unito 1.124
IT - Italia 941
IE - Irlanda 418
DE - Germania 401
UA - Ucraina 364
CN - Cina 233
VN - Vietnam 223
CA - Canada 206
SE - Svezia 174
HK - Hong Kong 92
DK - Danimarca 64
FI - Finlandia 53
FR - Francia 51
SG - Singapore 45
PK - Pakistan 38
EU - Europa 17
IN - India 13
RO - Romania 13
AT - Austria 12
NL - Olanda 11
BD - Bangladesh 10
CH - Svizzera 10
ES - Italia 10
IR - Iran 10
RU - Federazione Russa 10
JP - Giappone 9
ID - Indonesia 7
PL - Polonia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
CO - Colombia 3
HU - Ungheria 3
TH - Thailandia 3
AR - Argentina 2
AU - Australia 2
BR - Brasile 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
KR - Corea 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 9.665
Salva come PNG Salva come JPEG
Città #
Chandler 562
Southend 543
Fairfield 462
San Mateo 451
Dublin 414
Woodbridge 356
Houston 319
Cambridge 316
Wilmington 243
Falls Church 237
Seattle 230
Portsmouth 227
Stevenage 215
Ann Arbor 212
Ashburn 187
Ottawa 184
Jacksonville 175
Dearborn 156
Lawrence 155
Dong Ket 117
Beijing 108
Pisa 92
Boardman 90
Rome 85
San Diego 64
Milan 63
Brooklyn 42
Hong Kong 41
Florence 40
London 40
Fremont 38
Helsinki 37
Central District 34
Washington 27
Redwood City 26
Norwalk 23
Old Bridge 21
Buti 19
Livorno 19
Redmond 17
Guangzhou 15
Palermo 15
Dallas 14
Hounslow 13
Los Angeles 13
Medolago 13
Islamabad 12
Lucca 12
West Jordan 12
Bari 11
Chiswick 11
Genoa 11
Nanjing 11
Bologna 10
Bucharest 10
Frankfurt am Main 10
Cascina 9
Forlì 9
Montréal 9
Verona 9
Chicago 8
Dongguan 8
Shenzhen 8
Acton 7
Kilburn 7
Lahore 7
Tehran 7
Wandsworth 7
Amsterdam 6
Parma 6
Wuhan 6
Zirl 6
Albavilla 5
Malang 5
Naples 5
Pescia 5
Reggio Calabria 5
Toronto 5
Venice 5
Augusta 4
Bengaluru 4
Berlin 4
Bratislava 4
Brescia 4
Duncan 4
Gujranwala 4
Hanover 4
Lachine 4
Massa 4
Ruvo Di Puglia 4
Serra 4
Southwark 4
Taranto 4
Vienna 4
Agordo 3
Anzio 3
Birmingham 3
Cordenons 3
Custonaci 3
Faisalabad 3
Totale 7.112
Salva come PNG Salva come JPEG
Nome #
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 186
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 166
Treating chemoreflex in heart failure: modulation or demolition? 163
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 159
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 158
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 157
Building medical knowledge from real world registries: The case of heart failure 157
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 153
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 151
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 146
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 146
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 143
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 140
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 136
Cardiac light-chain deposition disease relapsing in the transplanted heart 123
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 119
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 117
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 116
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 105
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 104
Sex-related differences in chronic heart failure 101
How to take arms against central apneas in heart failure 96
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 94
Heart, kidney and FGF23: Les liaisons dangereuses 93
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 89
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 88
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 86
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure 86
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 83
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 83
A simple echocardiographic score to rule out cardiac amyloidosis 83
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 82
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 82
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 81
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 81
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 78
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 78
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 76
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 75
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 75
Cardiac troponins as biomarkers for cardiac disease 75
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 74
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 74
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 73
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure 72
Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies 72
Management of complications of cardiac amyloidosis: 10 questions and answers 72
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 71
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure 69
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 69
The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) 66
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 66
Amiodarone as a possible therapy for coronavirus infection 66
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 65
Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters 64
Therapies for cardiac light chain amyloidosis: An update 64
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 64
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 63
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 62
Sex-related differences in chronic heart failure 62
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 62
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome 62
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 59
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 58
Treatment of cardiac transthyretin amyloidosis: an update 57
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 56
How much is it to mend a broken heart? Results from the US Nationwide Readmission Database 53
Atrial amyloidosis: mechanisms and clinical manifestations 52
Longer sleep duration and poor sleep quality as risk factors for hyperlipidaemia 52
Use of biomarkers to diagnose and manage cardiac amyloidosis 51
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 50
Underprescription of disease-modifying drugs in chronic heart failure: More is better? 49
Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure 47
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 46
Biomarkers for the diagnosis and management of heart failure 46
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 46
Molecular autopsy of sudden cardiac death in the genomics era 46
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 45
Cardiovascular disease and COVID-19: les liaisons dangereuses 44
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 44
Unmet needs in end-of-life care for heart failure patients 43
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 42
Subclinical cardiac damage in cancer patients before chemotherapy 42
The Barthel Index in elderly acute heart failure patients. Frailty matters 41
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 41
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 40
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 40
Current and emerging drug targets in heart failure treatment 40
Colchicine for the treatment of coronary artery disease 39
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 39
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 39
Biomarkers for the diagnosis and management of heart failure: New frontiers 39
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 38
Role of Imaging in Cardiomyopathies 37
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 37
Aspirin and Prognosis in Heart Failure: A Question of Power 37
Natriuretic peptides. D'où venons-nous? Que sommes-nous? Où allons-nous? 37
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 37
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 36
Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure 36
Totale 7.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 13 8
2019/2020989 68 26 44 90 134 134 120 82 131 24 42 94
2020/20212.357 195 209 96 208 108 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.225 107 49 336 122 75 154 106 71 88 96 21 0
Totale 9.928